APA (7th ed.) Citation

Hedstrom, G., Thunberg, U., Amini, R., Zainuddin, N., Enblad, G., & Berglund, M. (2014). The MDM2 polymorphism SNP309 is associated with clinical characteristics and outcome in diffuse large B-cell lymphoma. John Wiley & Sons Ltd.

Chicago Style (17th ed.) Citation

Hedstrom, Gustav, Ulf Thunberg, Rose-Marie Amini, Norafiza Zainuddin, Gunilla Enblad, and Mattias Berglund. The MDM2 Polymorphism SNP309 Is Associated with Clinical Characteristics and Outcome in Diffuse Large B-cell Lymphoma. John Wiley & Sons Ltd, 2014.

MLA (8th ed.) Citation

Hedstrom, Gustav, et al. The MDM2 Polymorphism SNP309 Is Associated with Clinical Characteristics and Outcome in Diffuse Large B-cell Lymphoma. John Wiley & Sons Ltd, 2014.